Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)
CUSIP: 21833P301
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 17,685,185
- Total 13F shares
- 11,745,584
- Share change
- +967,340
- Total reported value
- $242,331,671
- Put/Call ratio
- 145%
- Price per share
- $20.63
- Number of holders
- 106
- Value change
- -$44,650,435
- Number of buys
- 69
- Number of sells
- 48
Quarterly Holders Quick Answers
What is CUSIP 21833P301?
CUSIP 21833P301 identifies CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 21833P301:
Top shareholders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP |
13F
|
Company |
11%
|
2,025,000
|
$91,631,250 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.3%
|
761,367
|
$34,451,857 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
584,989
|
$26,470,752 | — | 30 Jun 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
2.8%
|
488,000
|
$22,082,000 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
442,333
|
$20,015,568 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.3%
|
400,000
|
$18,100,000 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.9%
|
332,761
|
$15,057,435 | — | 30 Jun 2024 | |
| Darwin Global Management, Ltd. |
13F
|
Company |
1.8%
|
325,140
|
$14,267,143 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.8%
|
309,540
|
$14,006,685 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.7%
|
302,186
|
$13,674,000 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.5%
|
257,635
|
$11,657,983 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.4%
|
249,259
|
$11,278,970 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
241,649
|
$10,934,617 | — | 30 Jun 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.4%
|
238,759
|
$10,803,845 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
231,057
|
$10,457,660 | — | 30 Jun 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
1.3%
|
225,165
|
$10,188,716 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.2%
|
216,515
|
$9,797,304 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
1.2%
|
215,600
|
$9,755,900 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.1%
|
203,272
|
$9,190,943 | — | 30 Jun 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.99%
|
175,000
|
$7,918,750 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.98%
|
172,492
|
$7,805,263 | — | 30 Jun 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
0.94%
|
166,794
|
$7,547,429 | — | 30 Jun 2024 | |
| Rachael Louise Brake |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
1,400,000
|
$6,958,000 | — | 13 Feb 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.85%
|
150,391
|
$6,805,193 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.79%
|
140,300
|
$6,348,575 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.66%
|
116,271
|
$5,261,000 | — | 30 Jun 2024 | |
| Craig Stuart Millian |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
934,645
|
$4,645,186 | — | 13 Feb 2023 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.57%
|
101,479
|
$4,591,925 | — | 30 Jun 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.57%
|
100,000
|
$4,525,000 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.52%
|
91,728
|
$4,150,692 | — | 30 Jun 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.49%
|
86,349
|
$3,907,292 | — | 30 Jun 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.48%
|
84,790
|
$3,836,748 | — | 30 Jun 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.41%
|
72,842
|
$3,296,101 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.36%
|
64,503
|
$2,918,761 | — | 30 Jun 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.36%
|
64,500
|
$2,918,625 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.36%
|
63,059
|
$2,853,420 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.34%
|
60,528
|
$2,738,892 | — | 30 Jun 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.32%
|
56,468
|
$2,555,177 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.3%
|
53,087
|
$2,402,186 | — | 30 Jun 2024 | |
| Cinctive Capital Management LP |
13F
|
Company |
0.28%
|
49,013
|
$2,217,838 | — | 30 Jun 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.26%
|
45,364
|
$2,052,721 | — | 30 Jun 2024 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.25%
|
44,156
|
$1,998,059 | — | 30 Jun 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.24%
|
43,000
|
$1,945,750 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.23%
|
40,800
|
$1,846,200 | — | 30 Jun 2024 | |
| Atle Fund Management AB |
13F
|
Company |
0.22%
|
39,100
|
$1,769,275 | — | 30 Jun 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.22%
|
38,793
|
$1,755,383 | — | 30 Jun 2024 | |
| NEOS Investment Management LLC |
13F
|
Company |
0.21%
|
36,455
|
$1,649,589 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.19%
|
33,164
|
$1,500,671 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
30,236
|
$1,368,191 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.17%
|
30,124
|
$1,361,914 | — | 30 Jun 2024 |
Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) as of Q3 2024
As of 30 Sep 2024,
Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,745,584 shares.
The largest 10 holders included
Cormorant Asset Management, LP, Octagon Capital Advisors LP, ORBIMED ADVISORS LLC, BlackRock, Inc., VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, and Ikarian Capital, LLC.
This page lists
106
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
107
Q3 2024 holders
106
Holder diff
-1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.